[CERO] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CERO] CERo Therapeutics Holdings, Inc.
Announcement Date
28-Sep-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 76.50%
YoY- -492.94%
Quarter Report
CERO's Result
CERO's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 CAGR
Revenue 0 0 -
PBT -308 145 -312.41%
Tax 26 60 -56.66%
NP -334 85 -492.94%
Tax Rate - -41.71% -
Total Cost 334 -85 -492.94%
Ratio Analysis
30/09/23 30/09/22 CAGR
NP Margin 0.00 0.00 -
Per Share
30/09/23 30/09/22 CAGR
EPS -0.05 0.00 -
EPS Diluted -0.05 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.